History
•Inhaled anesthetics introduced
into clinical practice with the
successful use of nitrous oxide
in 1844 for dental anesthesia
followed by recognition of the
anestheticproperties of ether
in 1846 and of chloroform in
1847.
•Modern anesthetics, beginning
with halothane, differ from
prior anesthetics in being
fluorinated and nonflammable
Pharmacokinetics
•Absorption from alveoli into pulmonary capillary
blood
•Distribution in the body
•Metabolism
•Elimination
Input of anesthetics
Input of anesthetics into alveoli depends on
1.Inhaled partial pressure (PI)
2.Alveolar ventilation
3.Characteristics of the anesthetic breathing
2L 2L
2L
1L
50% O
2
50% N
2O
66 %O
2
33 % N
2O
2.5L
1.5L
62.5 %O
2
37.5 % N
2O
500 ml N
2O + 500 ml O
2
Augmentation of
tracheal inflow
Concentrating
effect
Inspired
After
diffusion
of N
2O
If 10% N
2Oand 90% O
2→the rise in alveolar concentration of N
2Owill be very low
5.3% by concentrating effect 5X
5.5. % by augmented inflow effect 6.8X compared to the 50:50 mixture
•Concentratingeffect:Halfofnitrousoxidediffusesquicklytoblood,alveolarvolumereducesto3000ml.
Thenewalveolarconcentrationofisofluraneis40/3000~1.33%.
•Augmentedinfloworventilationeffect:Duetosubatmosphericpressurecreatedinalveoli,further1lof
mixturegasisinhaled,i.e.10mlisoflurane,490mloxygenand500mlnitrousoxide.So,thenewalveolar
concentrationis(40+10)/4000~1.25%.
50% N
2O
40 ml
1.96 L
2L
500 ml N
2O + 490 ml O
2+ 10ml Isoflurane
Inspired
After
diffusion
of N
2O
49% O2
1% Isoflurane
33.3 % N
2O
40 ml
1.96 L
1L
65.3 %O2
1.3 % Isoflurane
37.5 % N
2O
61.25 % O2
1.25% Isoflurane
4 L 4 L3 L
Uptake of inhaled anesthetics
Uptake of inhaled anesthetics from alveoli into the pulmonary
capillary blood depends on
▪Solubility of the anesthetic in body tissues
▪Cardiac output
▪Alveolar-to-venouspartial pressure differences
MAC of Inhaled Anesthetics
▪Nitrous oxide 104
▪Halothane 0.75
▪Enflurane 1.63
▪Isoflurane 1.17
▪Desflurane 6.6
▪Sevoflurane 1.80
▪Xenon 70
Increase in MAC
▪Hyperthermia
▪Excess pheomelaninproduction (red hair)
▪Drug-induced increases in central nervous system
catecholamine levels
▪Cyclosporine
▪Hypernatremia
Decrease in MAC
▪Hypothermia
▪Increasing age
▪Preoperative medication
▪Drug-induced decreases in
central nervous system
catecholamine levels
▪a-2 agonists
▪Acute alcohol ingestion
▪Pregnancy
▪Postpartum (till 24–72 hours)
▪Lithium
▪Lidocaine
▪Neuraxial opioids (?)
▪PaO
2<38 mm Hg
▪Mean blood pressure<40
mmHg
▪Cardiopulmonary bypass
▪Hyponatremia
▪Linear relationship
between potency and
partition coefficient for
many types of
anaesthetics
▪Anaesthetic concentration
required to induce
anaesthesia in 50% of a
population of animals (the
EC
50) was independent of
the means by which the
anaesthetic was delivered,
i.e., the gas or aqueous
phase
Bulky and hydrophobic
anaesthetic molecules
accumulate inside the
neuronal cell membrane
causing its distortion and
expansion (thickening) due
to volume displacement.
Membranethickeningreversiblyaltersfunctionofmembraneionchannelsthus
providinganaestheticeffect.
Actualchemicalstructureoftheanaestheticagentpersewasnotimportant.
Butitsmolecularvolumeplaysthemajorrole:themorespacewithinmembrane
isoccupiedbyanaesthetic-thegreateristheanaestheticeffect.
N
2OHalothaneIsofluraneDesfluraneSevoflurane
Tidal
volume
⬇ ⬇⬇ ⬇⬇ ⬇ ⬇
Respiratory
Rate
⬆ ⬆⬆ ⬆ ⬆ ⬆
Effects on Respiratory system
CVS
▪N
2O stimulates Sympathetic NS→catecholamine stimulation
▪So, even though N
2O causes myocardial depression, BP, CO, HR unchanged
▪Reduction of arterial BP mainly due to myocardial depression
▪Reduction in mean arterial pressure by desflurane, sevoflurane, and isoflurane is primarily
determined by the reduction in systemic vascular resistance.
▪Normally, hypotension inhibits baroreceptors in the aortic arch and carotid bifurcation, causing a
decrease in vagal stimulation and a compensatory rise in heart rate. Halothane blunts this reflex.
▪Cardiac output maintained with isoflurane due to preservation of carotid baroreflexes.
▪Halothane sensitizes heart to arrthymogeniceffects of epinephrine→doseabove 1.5mcg/kg avoided
▪Isoflurane: Dilation of normal coronary arteries can divert blood away from fixed stenotic lesions
(Coronary steal)
▪Sevoflurane may prolong the QT interval, manifest 60 min following emergence in infants
•Ischaemicpreconditioning with inhalation anaesthetics may reduce perioperative myocardial
injury: K
ATPchannel activity increased→decrease in the voltage gradient, decrease in calcium ion
accumulation, the cardiac action potential shortens, negative inotropic action and remarkable
protection against subsequentmsustainedischemic
Renal
▪Productionofinorganicfluoridebythemetabolismof
halogenatedagentsmaycausedirectnephrotoxicity.
▪⬇Bloodflow,GFR,urineoutput⬇
(dueto⬆Renalvascularresistance,⬇arterialBPandCO)
▪Isofluraneismoreresistanttodefluorinationandcanbe
usedforprolongedperiodswithoutsignificantincreasesin
serumfluoridelevels
▪Preoperativehydrationlimitsthesechangesinrenal
function
Gastrointestinal
▪N
2O increases the risk of postoperative nausea and vomiting
▪Activation of chemoreceptor trigger zone and vomiting center in the
medulla
▪Extremely rare (1 per 35,000 cases)
–HalothaneoxidizedintheliverbyCYP2EI→principalmetabolite,trifluoroaceticacid
–Thismetabolismcanbeinhibitedbypretreatmentwithdisulfiram
▪Exposure to multiple halothane anesthetics at short intervals
▪Middle-aged obese women
▪Familial predisposition to halothane toxicity
▪Personal history of toxicity
▪Signs(are mostly related to hepatic injury)
▪increased serum alanine and aspartate transferase, elevated bilirubin (leading to
jaundice), and encephalopathy
▪Centrilobularnecrosis
▪Signs indicating an allergic reaction (eosinophilia, rash, fever) and do not
appear until a few days after exposure
Halothane hepatitis